Section 32: Ex-Google venture chief Maris pursues indie role with $230M biotech fund
As Bill Maris prepared to depart from his high-profile position as chief of Google’s venture arm, now called GV, he shrugged off questions about his next career act. But sources are telling Recode that he’s already well along the way to setting up an independent, $230 million fund of his own, where he’ll be going back to pursuing a deep interest in biotech and healthcare.
The new group is called Section 32, an evident reference to the autonomous Section 31 intelligence group featured in Star Trek. In keeping with the tech industry’s deep reluctance to discuss anything about new programs or technologies that have yet to be prepped for public consumption, Maris wasn’t talking on Monday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.